Vaxxinity OverviewVaxxinity Research & Development
Research & Development expenses for VAXX.
Quarterly R&D Expenses
$7.76M
↓ 40.36% YoY
As of Dec 31, 2023
Annual R&D Expenses (TTM)
$35.44M
↓ 25.58% YoY
Trailing 12 months ending Dec 31, 2023
Vaxxinity OverviewResearch & Development expenses for VAXX.
As of Dec 31, 2023
Trailing 12 months ending Dec 31, 2023